Product Information

TADALAFIL 2.5 MG TABLET is a generic product labeled by Ajanta Pharma USA Inc., priced at $0.1164 per EA under NDC 27241011105. Its NADAC has been published 294 times since Jan 6, 2021.

FDA first approved this application on Mar 26, 2019. Its Orange Book therapeutic-equivalence code is AB1 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TADALAFIL 2.5 MG TABLET

Tadalafil
$0.1164per EA

Strength

2.5 mg/1

NDC

27241011105

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

TADALAFIL

Approval Type

Generic (ANDA)

FDA Application

ANDA209654

FDA Approved

3/26/2019

TE Code

AB1

On Market Since

3/26/2019

Pharmacological Classes

Phosphodiesterase 5 Inhibitor
Phosphodiesterase 5 Inhibitors

Price Statistics

The NADAC for TADALAFIL 2.5 MG TABLET has been published 294 times since Jan 6, 2021, and over the history we have for it it has declined 35.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.1164 per EA
All-time high$0.2819 (Mar 10, 2021)
All-time low$0.0828 (Jul 17, 2024)
52-week high$0.1298
52-week low$0.1143
Median price$0.1576
Average price$0.1581
Largest weekly change+53.6% (Aug 21, 2024)
Weeks tracked294
Tracking sinceJan 6, 2021

Price History

1W

+1.9%

1M

+1.9%

3M

-1.0%

6M

-4.8%

1Y

-10.3%

3Y

-34.2%

5Y

-31.0%

All

-35.6%

Generic Alternatives

The matcher finds 12 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of TADALAFIL 2.5 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for TADALAFIL 2.5 MG TABLET, manufactured by Ajanta Pharma USA Inc., is $0.1164 per EA (NDC 27241011105), effective Aug 19, 2026.

How has the price of TADALAFIL 2.5 MG TABLET changed over time?

Over the history we have for it, the NADAC for TADALAFIL 2.5 MG TABLET has declined 35.6%. It has been tracked across 294 weekly CMS publications since Jan 6, 2021.

What are the highest and lowest recorded NADAC prices for TADALAFIL 2.5 MG TABLET?

Since Jan 6, 2021, the NADAC for TADALAFIL 2.5 MG TABLET has ranged from a low of $0.0828 (Jul 17, 2024) to a high of $0.2819 (Mar 10, 2021), with a median of $0.1576 per EA.

Are there cheaper alternatives to TADALAFIL 2.5 MG TABLET?

Yes. 12 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TADALAFIL 2.5 MG TABLET, is $0.1124 per EA — about 3% below TADALAFIL 2.5 MG TABLET.

Who manufactures TADALAFIL 2.5 MG TABLET?

TADALAFIL 2.5 MG TABLET (NDC 27241011105) is labeled by Ajanta Pharma USA Inc., and CMS classifies it as a generic product.